Status:
NOT_YET_RECRUITING
Arthroscopic Treatment of Rotator Cuff Tears
Lead Sponsor:
Peking University Third Hospital
Conditions:
Rotator Cuff
Eligibility:
All Genders
18-70 years
Brief Summary
Rotator cuff tears are the primary cause of shoulder pain and functional impairment, accounting for 50% to 85% of shoulder disorders. With the acceleration of population aging in China and the increas...
Eligibility Criteria
Inclusion
- Age 18 to 70 years
- Primary arthroscopic rotator cuff repair
- Full-thickness rotator cuff tear confirmed by clinical examination and magnetic resonance imaging (MRI)
- Patient has signed the informed consent form
- Patient is willing and able to participate in follow-up and evaluation procedures
Exclusion
- Partial rotator cuff tear or irreparable massive tear
- Concurrent shoulder pathologies other than rotator cuff injury, such as frozen shoulder or shoulder instability
- History of significant trauma to the ipsilateral shoulder
- History of previous surgery on the ipsilateral shoulder
- Presence of severe systemic diseases, such as tumors or severe dysfunction of internal organs
Key Trial Info
Start Date :
May 30 2025
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 31 2027
Estimated Enrollment :
600 Patients enrolled
Trial Details
Trial ID
NCT06961318
Start Date
May 30 2025
End Date
December 31 2027
Last Update
May 25 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Peking University Third Hospital
Beijing, Beijing Municipality, China, 100191